Výsledky vyhledávání - "Anicet Chaslerie"

Akademický článek

(De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database

Autor: Pauline Gendre, Julie Mocquard, Pascal Artarit, Anicet Chaslerie, Pascal Caillet, Jean-François Huon

Publikováno v: BMC Primary Care, Vol 23, Iss 1, Pp 1-7 (2022)

Abstract Background Proton pump inhibitors (PPIs) are one of the most widely prescribed drug classes in the community and at hospital. The significant misuse of PPIs requires the implementation for a deprescribing strategy. Numerous studies aiming at

Externí odkaz: https://doaj.org/article/a49db090c07b43bfaa6b1a2125505c3c

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data

Autor: Edouard-Jules Laforgue, Marion Istvan, Anicet Chaslerie, Pascal Artarit, Geneviève Vallot, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vigneau

Publikováno v: Epidemiology and Psychiatric Sciences, Vol 32 (2023)

Abstract Aims Despite recommendations to initiate clozapine after two unsuccessful trials of antipsychotics, clozapine is underprescribed and initiated too late. The aim of this study was to describe different antipsychotic treatment sequences in the

Externí odkaz: https://doaj.org/article/45c33a87ea8a4982922732cdfc5c96c5

Zobrazit plný text záznamu

Akademický článek

Inclusion of populations at risk of advanced melanoma in an opportunistic targeted screening project involving general practitioners

Autor: Cédric Rat, Gaelle Quereux, Charlotte Grimault, Jérémy Fernandez, Mickael Poiraud, Aurélie Gaultier, Anicet Chaslerie, Jacques Pivette, Amir Khammari, Brigitte Dreno, Jean-Michel Nguyen

Publikováno v: Scandinavian Journal of Primary Health Care, Vol 34, Iss 3, Pp 286-294 (2016)

Objective: The study objective was to measure the rates of inclusion of populations at risk of advanced melanoma in a pilot targeted screening project involving general practitioners. Design: This cross-sectional database study compared the inclusion

Externí odkaz: https://doaj.org/article/a0ac37a3377b4bfd9e868ed23bddfa74

Zobrazit plný text záznamu

Plný text ve formátu HTML

Expert consensus on monitoring antimicrobial stewardship in French nursing homes using assessed reimbursement database indicators

Autor: Antoine Asquier-Khati, Colin Deschanvres, Anicet Chaslerie, Ouarda Pereira, David Boutoille, Gabriel Birgand

Publikováno v: JAC-Antimicrobial Resistance. 5

Objectives Monitoring the appropriateness of antibiotic prescriptions with indicators based on reimbursement data is required to guide antibiotic stewardship (AMS) interventions in nursing homes (NHs). Quantity metrics (QMs) monitor the volume of pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e144c4e501940977a6b6224df54024
https://doi.org/10.1093/jacamr/dlad037

Zobrazit plný text záznamu

Advocacy for better metabolic monitoring after antipsychotic initiation: based on data from a French health insurance database

Autor: Anicet Chaslerie, Samuel Bulteau, Caroline Victorri-Vigneau, Marine Le Pierres, Olivier Bonnot, Emmanuelle Michaud, Bastien Forestier, Pascal Artarit

Publikováno v: Expert Opinion on Drug Safety. 20:225-233

Background: Nearly 3% of the population is treated by antipsychotic. The aim of this study was to assess the conformity of monitoring with guidelines to prevent Metabolic Syndrome. Research design ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658b77be651b018f2a31b9506384160f
https://doi.org/10.1080/14740338.2021.1851678

Zobrazit plný text záznamu

What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database: A compliance analysis using the French health insurance database

Autor: Pascal Artarit, Marie Grall-Bronnec, Caroline Victorri-Vigneau, Marylène Guerlais, Marion Istvan, Edouard-Jules Laforgue, Genevieve Vallot, Anicet Chaslerie, Pascale Jolliet

Publikováno v: Expert Opinion on Drug Safety
Expert Opinion on Drug Safety, Informa Healthcare, 2021, 20 (10), pp.1247-1256. ⟨10.1080/14740338.2021.1939304⟩

The inherent risk of agranulocytosis associated with clozapine requires the realization of weekly white blood cell monitoring (WBCM) during the 18 first weeks of treatment. The aim of this study was to assess the compliance with WBCM during clozapine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab51d82e987767298c8db418e8f93d1
https://hal-univ-tours.archives-ouvertes.fr/hal-03406940

Zobrazit plný text záznamu

Qu’en est-il de la surveillance hématologique à l’initiation d’un traitement par clozapine ? Une analyse de compliance à partir de la base de données de l’assurance maladie

Autor: Pascal Artarit, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vigneau, Marylène Guerlais, Edouard-Jules Laforgue, Anicet Chaslerie, Marion Istvan, Genevieve Vallot

Publikováno v: Revue d'Épidémiologie et de Santé Publique. 69:S95-S96

Introduction La clozapine est le traitement de reference des schizophrenies (SZ) resistantes et le seul antipsychotique autorise dans la maladie de parkinson (MP) [1] , [2] . Le risque d’agranulocytose medicamenteuse auquel la prescription de cloza

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::140566dac90b43a162c2fa71e9cc4153
https://doi.org/10.1016/j.respe.2021.05.021

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání